Topics Topics

Olainfarm to deliver $1m worth of TB drug to World Health Organization

In the first quarter of 2019, Latvia's Olainfarm will deliver second-line anti-tubercular drugs worth $1 million to the World Health Organization.

In particular, Olainfarm is to provide Aminosalicylic Acid, used by the WHO to treat tuberculosis in developing countries in Asia and Africa.

Olainfarm has been producing the drug since 2001. Inter alia, it delivers Aminosalicylic Acid to clinics in the Baltics and to the international NGO, Médecins Sans Frontières, the company told the press. 

Seen a mistake?

Select text and press Ctrl+Enter to send a suggested correction to the editor

Select text and press Report a mistake to send a suggested correction to the editor


Please be aware that the LSM portal uses cookies. By continuing to use this site, you agree that we may store and use cookies on your device. Find out more

Accept and continue